Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology

BackgroundThe hybrid arch repair (HAR) is an appealing surgical option in the management of aortic arch diseases. The aim is to evaluate the short and mid-term outcomes of type II HAR involving replacement of the ascending aorta, arch debranching, and zone 0 stent graft deployment in diverse arch pa...

Full description

Bibliographic Details
Main Authors: Yanxiang Liu, Bowen Zhang, Shenghua Liang, Yaojun Dun, Hongwei Guo, Xiangyang Qian, Cuntao Yu, Xiaogang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.882783/full
_version_ 1828331755432574976
author Yanxiang Liu
Bowen Zhang
Shenghua Liang
Yaojun Dun
Hongwei Guo
Xiangyang Qian
Cuntao Yu
Xiaogang Sun
author_facet Yanxiang Liu
Bowen Zhang
Shenghua Liang
Yaojun Dun
Hongwei Guo
Xiangyang Qian
Cuntao Yu
Xiaogang Sun
author_sort Yanxiang Liu
collection DOAJ
description BackgroundThe hybrid arch repair (HAR) is an appealing surgical option in the management of aortic arch diseases. The aim is to evaluate the short and mid-term outcomes of type II HAR involving replacement of the ascending aorta, arch debranching, and zone 0 stent graft deployment in diverse arch pathologies.Methods200 patients with various diffuse aortic pathologies involving the arch were enrolled between 2016 and 2019. Complex arch diseases included acute type A dissection (n = 129, 64.5%), acute type B dissection (n = 16, 8.0%), aortic arch aneurysm (n = 42, 21.0%) and penetrating arch ulcer (n = 13, 6.5%). Mortality, morbidity, survival and re-intervention were analyzed.ResultsThe overall 30-day mortality rate was 8.0% (16/200). Stroke was present in 3.5% (7/200) of the general cohort and spinal cord injury was occurred in 3.0% (6/200). Multivariable logistic analysis showed that cardiac malperfusion and CPB time were the risk factors associated with 30-day mortality. The mean follow-up duration was 25.9 months (range 1–57.2 months), and the 3-year survival rate was 83.1%. On Cox regression analysis, age, diabetes, cardiac malperfusion and CPB time predicted short and mid-term overall mortality. A total of 3 patients required reintervention during the follow-up due to the thrombosis of epiaortic artificial vessels (n = 1), anastomotic leak at the site of the proximal ascending aorta (n = 1) and the type I endoleak (n = 1).ConclusionsType II HAR was performed with satisfactory early and mid-term outcomes in complex aortic arch pathologies.
first_indexed 2024-04-13T20:57:22Z
format Article
id doaj.art-d41c2d42b64c4b5b95b2bff48ff0952c
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-13T20:57:22Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-d41c2d42b64c4b5b95b2bff48ff0952c2022-12-22T02:30:17ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-06-01910.3389/fcvm.2022.882783882783Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch PathologyYanxiang LiuBowen ZhangShenghua LiangYaojun DunHongwei GuoXiangyang QianCuntao YuXiaogang SunBackgroundThe hybrid arch repair (HAR) is an appealing surgical option in the management of aortic arch diseases. The aim is to evaluate the short and mid-term outcomes of type II HAR involving replacement of the ascending aorta, arch debranching, and zone 0 stent graft deployment in diverse arch pathologies.Methods200 patients with various diffuse aortic pathologies involving the arch were enrolled between 2016 and 2019. Complex arch diseases included acute type A dissection (n = 129, 64.5%), acute type B dissection (n = 16, 8.0%), aortic arch aneurysm (n = 42, 21.0%) and penetrating arch ulcer (n = 13, 6.5%). Mortality, morbidity, survival and re-intervention were analyzed.ResultsThe overall 30-day mortality rate was 8.0% (16/200). Stroke was present in 3.5% (7/200) of the general cohort and spinal cord injury was occurred in 3.0% (6/200). Multivariable logistic analysis showed that cardiac malperfusion and CPB time were the risk factors associated with 30-day mortality. The mean follow-up duration was 25.9 months (range 1–57.2 months), and the 3-year survival rate was 83.1%. On Cox regression analysis, age, diabetes, cardiac malperfusion and CPB time predicted short and mid-term overall mortality. A total of 3 patients required reintervention during the follow-up due to the thrombosis of epiaortic artificial vessels (n = 1), anastomotic leak at the site of the proximal ascending aorta (n = 1) and the type I endoleak (n = 1).ConclusionsType II HAR was performed with satisfactory early and mid-term outcomes in complex aortic arch pathologies.https://www.frontiersin.org/articles/10.3389/fcvm.2022.882783/fullhybrid arch repair (HAR)aortic arch pathologyaortic dissection (AD)arch aneurysmdeep hypothermic circulatory arrest
spellingShingle Yanxiang Liu
Bowen Zhang
Shenghua Liang
Yaojun Dun
Hongwei Guo
Xiangyang Qian
Cuntao Yu
Xiaogang Sun
Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology
Frontiers in Cardiovascular Medicine
hybrid arch repair (HAR)
aortic arch pathology
aortic dissection (AD)
arch aneurysm
deep hypothermic circulatory arrest
title Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology
title_full Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology
title_fullStr Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology
title_full_unstemmed Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology
title_short Early and Midterm Outcomes of Type II Hybrid Arch Repair for Complex Aortic Arch Pathology
title_sort early and midterm outcomes of type ii hybrid arch repair for complex aortic arch pathology
topic hybrid arch repair (HAR)
aortic arch pathology
aortic dissection (AD)
arch aneurysm
deep hypothermic circulatory arrest
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.882783/full
work_keys_str_mv AT yanxiangliu earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT bowenzhang earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT shenghualiang earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT yaojundun earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT hongweiguo earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT xiangyangqian earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT cuntaoyu earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology
AT xiaogangsun earlyandmidtermoutcomesoftypeiihybridarchrepairforcomplexaorticarchpathology